End-of-day quote
Shenzhen S.E.
23:00:00 13/05/2024 BST
|
5-day change
|
1st Jan Change
|
4.41
CNY
|
+3.04%
|
|
-5.77%
|
-31.73%
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
1,143
|
1,528
|
1,918
|
2,180
|
1,547
|
1,837
|
Enterprise Value (EV)
1 |
1,409
|
1,738
|
2,237
|
2,520
|
1,896
|
2,235
|
P/E ratio
|
-11.4
x
|
145
x
|
-31.6
x
|
183
x
|
-13
x
|
-18.6
x
|
Yield
|
-
|
-
|
-
|
0.31%
|
-
|
-
|
Capitalization / Revenue
|
0.96
x
|
1.62
x
|
2.06
x
|
2
x
|
1.98
x
|
3.29
x
|
EV / Revenue
|
1.18
x
|
1.84
x
|
2.41
x
|
2.31
x
|
2.43
x
|
4
x
|
EV / EBITDA
|
24.7
x
|
24
x
|
106
x
|
29.5
x
|
-19.8
x
|
800
x
|
EV / FCF
|
6.08
x
|
30.6
x
|
-22.2
x
|
256
x
|
49.1
x
|
120
x
|
FCF Yield
|
16.5%
|
3.27%
|
-4.51%
|
0.39%
|
2.04%
|
0.84%
|
Price to Book
|
1.36
x
|
1.87
x
|
2.54
x
|
2.85
x
|
2.42
x
|
3.62
x
|
Nbr of stocks (in thousands)
|
296,407
|
289,210
|
289,210
|
289,210
|
289,210
|
284,373
|
Reference price
2 |
3.856
|
5.285
|
6.631
|
7.538
|
5.350
|
6.460
|
Announcement Date
|
24/04/19
|
24/04/20
|
26/04/21
|
22/04/22
|
26/04/23
|
24/04/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
1,195
|
943.8
|
928.8
|
1,089
|
780.2
|
558.4
|
EBITDA
1 |
57.03
|
72.46
|
21.07
|
85.3
|
-95.98
|
2.792
|
EBIT
1 |
16.85
|
27.67
|
-25.04
|
40.36
|
-144
|
-40.69
|
Operating Margin
|
1.41%
|
2.93%
|
-2.7%
|
3.71%
|
-18.45%
|
-7.29%
|
Earnings before Tax (EBT)
1 |
-105
|
6.42
|
-75.12
|
8.042
|
-152.1
|
-94.17
|
Net income
1 |
-100.5
|
10.78
|
-60.74
|
11.92
|
-118.8
|
-100.2
|
Net margin
|
-8.41%
|
1.14%
|
-6.54%
|
1.1%
|
-15.22%
|
-17.95%
|
EPS
2 |
-0.3385
|
0.0365
|
-0.2100
|
0.0412
|
-0.4106
|
-0.3480
|
Free Cash Flow
1 |
231.7
|
56.81
|
-100.9
|
9.839
|
38.62
|
18.67
|
FCF margin
|
19.39%
|
6.02%
|
-10.87%
|
0.9%
|
4.95%
|
3.34%
|
FCF Conversion (EBITDA)
|
406.34%
|
78.4%
|
-
|
11.53%
|
-
|
668.75%
|
FCF Conversion (Net income)
|
-
|
527.19%
|
-
|
82.51%
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
0.0231
|
-
|
-
|
Announcement Date
|
24/04/19
|
24/04/20
|
26/04/21
|
22/04/22
|
26/04/23
|
24/04/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
266
|
210
|
319
|
340
|
349
|
398
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
4.656
x
|
2.896
x
|
15.15
x
|
3.984
x
|
-3.635
x
|
142.5
x
|
Free Cash Flow
1 |
232
|
56.8
|
-101
|
9.84
|
38.6
|
18.7
|
ROE (net income / shareholders' equity)
|
-11.3%
|
1.15%
|
-7.77%
|
1.99%
|
-16.5%
|
-17.1%
|
ROA (Net income/ Total Assets)
|
0.59%
|
1.02%
|
-0.98%
|
1.58%
|
-5.77%
|
-1.85%
|
Assets
1 |
-17,090
|
1,058
|
6,187
|
752.9
|
2,058
|
5,407
|
Book Value Per Share
2 |
2.830
|
2.820
|
2.610
|
2.650
|
2.210
|
1.780
|
Cash Flow per Share
2 |
0.9800
|
0.9700
|
0.5500
|
0.6700
|
0.7400
|
0.5700
|
Capex
1 |
32.3
|
51
|
11.1
|
22.8
|
24.1
|
26
|
Capex / Sales
|
2.7%
|
5.4%
|
1.2%
|
2.1%
|
3.08%
|
4.65%
|
Announcement Date
|
24/04/19
|
24/04/20
|
26/04/21
|
22/04/22
|
26/04/23
|
24/04/24
|
|
1st Jan change
|
Capi.
|
---|
| -31.73% | 173M | | +16.91% | 66.22B | | +3.80% | 49.24B | | +17.19% | 41.4B | | +21.48% | 26.62B | | +13.44% | 19.84B | | +2.79% | 17.44B | | -6.24% | 15.92B | | -23.54% | 15.57B | | +2.37% | 15.45B |
Other Specialty Chemicals
|